Quanterix (QTRX)
3.84
-0.13 (3.27%)
Upcoming Events
Latest Headlines
Form 4 Quanterix Corp For: Jul 15 Filed by: Miller Michael Francis
July 16, 2026 5:34 PM - SEC Filing
Form 4 Quanterix Corp For: Jul 15 Filed by: Faessler Jason F.
July 16, 2026 5:32 PM - SEC Filing
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2026 4:05 PM - BizWire
Anthem to cover Quanterix Alzheimer's blood test starting July 2026
July 14, 2026 4:29 PM - StreetInsider
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
July 14, 2026 4:29 PM - BizWire
Form 4 Quanterix Corp For: Jul 08 Filed by: Mendel Scott
July 9, 2026 5:20 PM - SEC Filing
Form 4 Quanterix Corp For: Jul 08 Filed by: LAI GOLDMAN MYLA
July 9, 2026 5:19 PM - SEC Filing
Form 4 Quanterix Corp For: Jul 01 Filed by: Mendel Scott
July 2, 2026 4:04 PM - SEC Filing
Form 4 Quanterix Corp For: Jul 01 Filed by: DONNELLY WILLIAM P
July 2, 2026 4:03 PM - SEC Filing
Form 4 Quanterix Corp For: Jun 30 Filed by: Miller Michael Francis
July 2, 2026 4:02 PM - SEC Filing
Form 4 Quanterix Corp For: Jun 15 Filed by: Sriram Vandana
June 23, 2026 5:06 PM - SEC Filing
Form 3 Quanterix Corp For: Jun 22 Filed by: Faessler Jason F.
June 22, 2026 4:19 PM - SEC Filing
Form 4 Quanterix Corp For: Jun 15 Filed by: Miller Michael Francis
June 16, 2026 4:07 PM - SEC Filing
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2026 4:01 PM - BizWire
Form 4 Quanterix Corp For: May 12 Filed by: Meadows Benjamin
June 12, 2026 5:32 PM - SEC Filing
Form 3 Quanterix Corp For: Feb 23 Filed by: Meadows Benjamin
June 12, 2026 5:30 PM - SEC Filing
Form 8-K Quanterix Corp For: Jun 09
June 10, 2026 4:17 PM - SEC Filing
Form 8-K Quanterix Corp For: Jun 09
June 9, 2026 8:07 AM - SEC Filing
Quanterix names Jason Faessler as chief financial officer
June 9, 2026 8:03 AM - StreetInsider
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer
June 9, 2026 8:03 AM - BizWire
Quanterix names Geoff Albrecht as diagnostics business head
June 4, 2026 8:02 AM - StreetInsider
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
June 4, 2026 8:02 AM - BizWire
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
June 3, 2026 8:01 AM - BizWire
Form 4 Quanterix Corp For: May 31 Filed by: Miller Michael Francis
June 1, 2026 4:08 PM - SEC Filing
Form 8-K Quanterix Corp For: May 14
May 26, 2026 5:26 PM - SEC Filing
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 26, 2026 4:01 PM - BizWire
Form 4 Quanterix Corp For: May 15 Filed by: Sriram Vandana
May 18, 2026 5:35 PM - SEC Filing
Form 4 Quanterix Corp For: May 15 Filed by: Miller Michael Francis
May 18, 2026 5:34 PM - SEC Filing
Form SCHEDULE 13G/A Quanterix Corp Filed by: Portolan Capital Management, LLC
May 15, 2026 4:12 PM - SEC Filing
Form SCHEDULE 13G/A Quanterix Corp Filed by: AMERIPRISE FINANCIAL INC
May 15, 2026 10:37 AM - SEC Filing
Form 8-K Quanterix Corp For: May 11
May 12, 2026 4:17 PM - SEC Filing
Quanterix CFO Vandana Sriram to depart company in June 2026
May 12, 2026 4:01 PM - StreetInsider
Quanterix Announces Planned Transition of Chief Financial Officer
May 12, 2026 4:01 PM - BizWire
Form DEFA14A Quanterix Corp
May 8, 2026 4:01 PM - SEC Filing
Form SCHEDULE 13G/A Quanterix Corp Filed by: AMERIPRISE FINANCIAL INC
May 7, 2026 10:20 AM - SEC Filing
Quanterix Corp. (QTRX) PT Lowered to $4 at TD Cowen
May 7, 2026 8:53 AM - StreetInsider
Form 10-Q Quanterix Corp For: Mar 31
May 6, 2026 4:39 PM - SEC Filing
Quanterix (QTRX) Tops Q1 EPS by 10c, provides guidance
May 6, 2026 4:25 PM - StreetInsider
Form 8-K Quanterix Corp For: May 06
May 6, 2026 4:08 PM - SEC Filing
Quanterix Releases Financial Results for the First Quarter of 2026
May 6, 2026 4:01 PM - BizWire
Lucent Diagnostics partners with Tempus AI for Alzheimer's blood testing
May 6, 2026 8:02 AM - StreetInsider
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows
May 6, 2026 8:00 AM - BizWire
Form 4 Quanterix Corp For: Apr 30 Filed by: Miller Michael Francis
May 1, 2026 4:21 PM - SEC Filing
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
April 24, 2026 8:33 AM - BizWire
Form ARS Quanterix Corp For: Dec 31
April 24, 2026 8:12 AM - SEC Filing
Form DEF 14A Quanterix Corp For: Jun 09
April 24, 2026 8:11 AM - SEC Filing
Full Article List